DocGo Inc.
DCGO
$3.03
$0.103.41%
| Weiss Ratings | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.48 | |||
| Price History | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -25.37% | |||
| 30-Day Total Return | -32.37% | |||
| 60-Day Total Return | -25.74% | |||
| 90-Day Total Return | -10.09% | |||
| Year to Date Total Return | -29.37% | |||
| 1-Year Total Return | -20.05% | |||
| 2-Year Total Return | -66.33% | |||
| 3-Year Total Return | -52.73% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -48.37% | |||
| 52-Week Low % Change | 6.55% | |||
| Price | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.68 | |||
| 52-Week Low Price | $2.75 | |||
| 52-Week Low Price (Date) | Jul 10, 2024 | |||
| 52-Week High Price (Date) | Feb 18, 2025 | |||
| Valuation | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 298.81M | |||
| Enterprise Value | 261.02M | |||
| Price/Earnings (TTM) | 16.71 | |||
| Earnings Per Share (TTM) | 0.18 | |||
| Earnings Per Share Growth | 183.20% | |||
| Price/Earnings To Growth | 0.09 | |||
| Price/Sales (TTM) | 0.52 | |||
| Price/Book (Q) | 0.93 | |||
| Enterprise Value/Revenue (TTM) | 0.42 | |||
| Price | $3.03 | |||
| Enterprise Value/EBITDA (TTM) | 5.86 | |||
| Enterprise Value/EBIT | 9.10 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 109.42M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 443 6246 | |||
| Address | 685 Third Avenue New York, NY 10017 | |||
| Website | www.docgo.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 4.65% | |||
| Profit Margin | 3.24% | |||
| Management Effectiveness | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.79% | |||
| Return on Equity | 4.31% | |||
| Income Statement | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 616.56M | |||
| Total Revenue (TTM) | 616.56M | |||
| Revenue Per Share | $5.63 | |||
| Gross Profit (TTM) | 213.57M | |||
| EBITDA (TTM) | 44.57M | |||
| EBIT (TTM) | 28.69M | |||
| Net Income (TTM) | 19.99M | |||
| Net Income Avl. to Common (TTM) | 19.99M | |||
| Total Revenue Growth (Q YOY) | -39.35% | |||
| Earnings Growth (Q YOY) | -195.67% | |||
| EPS Diluted (TTM) | 0.18 | |||
| EPS Diluted Growth (Q YOY) | -149.71% | |||
| Balance Sheet | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 89.24M | |||
| Cash Per Share (Q) | $0.82 | |||
| Total Current Assets (Q) | 304.49M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 315.18M | |||
| Current Ratio (Q) | 2.500 | |||
| Book Value Per Share (Q) | $3.15 | |||
| Total Assets (Q) | 455.62M | |||
| Total Current Liabilities (Q) | 121.81M | |||
| Total Debt (Q) | 57.19M | |||
| Total Liabilities (Q) | 140.44M | |||
| Total Common Equity (Q) | 320.92M | |||
| Cash Flow | DCGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.87M | |||
| Cash from Financing (TTM) | -24.15M | |||
| Net Change in Cash (TTM) | 35.12M | |||
| Levered Free Cash Flow (TTM) | 48.59M | |||
| Cash from Operations (TTM) | 70.34M | |||
